Brighten Optix Corporation
Brighten Optix Corporation researches, develops, manufactures, and sells contact lenses in Taiwan and internationally. The company offers orthokeratology, a non-invasive and reversible method of vision correction by using a hard contact lens to alter the shape of the front surface of the cornea; gas permeable lenses for single vison, multifocal, and irregular cornea and keratoconus correction, un… Read more
Brighten Optix Corporation (6747) - Net Assets
Latest net assets as of September 2025: NT$1.16 Billion TWD
Based on the latest financial reports, Brighten Optix Corporation (6747) has net assets worth NT$1.16 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.49 Billion) and total liabilities (NT$331.68 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$1.16 Billion |
| % of Total Assets | 77.72% |
| Annual Growth Rate | 22.08% |
| 5-Year Change | 94.26% |
| 10-Year Change | N/A |
| Growth Volatility | 24.63 |
Brighten Optix Corporation - Net Assets Trend (2017–2024)
This chart illustrates how Brighten Optix Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Brighten Optix Corporation (2017–2024)
The table below shows the annual net assets of Brighten Optix Corporation from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.41 Billion | +10.65% |
| 2023-12-31 | NT$1.28 Billion | +2.99% |
| 2022-12-31 | NT$1.24 Billion | +4.64% |
| 2021-12-31 | NT$1.19 Billion | +62.90% |
| 2020-12-31 | NT$728.17 Million | +2.87% |
| 2019-12-31 | NT$707.86 Million | +59.86% |
| 2018-12-31 | NT$442.81 Million | +26.51% |
| 2017-12-31 | NT$350.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Brighten Optix Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 190.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$532.95 Million | 37.76% |
| Other Components | NT$878.43 Million | 62.24% |
| Total Equity | NT$1.41 Billion | 100.00% |
Brighten Optix Corporation Competitors by Market Cap
The table below lists competitors of Brighten Optix Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Samart Corporation Public Company Limited
BK:SAMART
|
$71.17 Million |
|
Embassy Bancorp Inc
OTCQX:EMYB
|
$71.17 Million |
|
Formosa Electronic Industries
TWO:8171
|
$71.18 Million |
|
OPC Energy Ltd
TA:OPCE
|
$71.19 Million |
|
BIEN SPAREB.AS NK 34375
F:JX0
|
$71.13 Million |
|
Seer Inc
NASDAQ:SEER
|
$71.12 Million |
|
Soosan Industries Co. Ltd.
KO:126720
|
$71.09 Million |
|
Atland S.A.
PA:ATLD
|
$71.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Brighten Optix Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,273,107,000 to 1,411,381,000, a change of 138,274,000 (10.9%).
- Net income of 149,793,000 contributed positively to equity growth.
- Dividend payments of 130,000,000 reduced retained earnings.
- Other factors increased equity by 118,481,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$149.79 Million | +10.61% |
| Dividends Paid | NT$130.00 Million | -9.21% |
| Other Changes | NT$118.48 Million | +8.39% |
| Total Change | NT$- | 10.86% |
Book Value vs Market Value Analysis
This analysis compares Brighten Optix Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.84x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.51x to 3.84x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$15.91 | NT$199.00 | x |
| 2018-12-31 | NT$20.08 | NT$199.00 | x |
| 2019-12-31 | NT$32.09 | NT$199.00 | x |
| 2020-12-31 | NT$32.87 | NT$199.00 | x |
| 2021-12-31 | NT$49.01 | NT$199.00 | x |
| 2022-12-31 | NT$50.93 | NT$199.00 | x |
| 2023-12-31 | NT$52.46 | NT$199.00 | x |
| 2024-12-31 | NT$51.89 | NT$199.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Brighten Optix Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.61%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 19.53%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.13x
- Recent ROE (10.61%) is below the historical average (16.76%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 16.59% | 17.85% | 0.50x | 1.85x | NT$23.08 Million |
| 2018 | 16.66% | 18.27% | 0.65x | 1.41x | NT$29.40 Million |
| 2019 | 16.33% | 23.61% | 0.58x | 1.20x | NT$44.69 Million |
| 2020 | 17.23% | 23.11% | 0.62x | 1.20x | NT$52.47 Million |
| 2021 | 20.36% | 37.41% | 0.47x | 1.16x | NT$122.75 Million |
| 2022 | 20.65% | 34.33% | 0.52x | 1.16x | NT$131.80 Million |
| 2023 | 15.65% | 26.66% | 0.50x | 1.16x | NT$71.93 Million |
| 2024 | 10.61% | 19.53% | 0.48x | 1.13x | NT$8.65 Million |
Industry Comparison
This section compares Brighten Optix Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,274,214,400
- Average return on equity (ROE) among peers: 6.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Brighten Optix Corporation (6747) | NT$1.16 Billion | 16.59% | 0.29x | $71.13 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |